Skip to main content
. 2016 Oct 22;7(50):82961–82971. doi: 10.18632/oncotarget.12821

Table 2. The expression of CDH4 and CDH1 in clinical and pathological characteristics of SACC.

Characteristics For CDH4 For CDH1
Total Low CDH4* High CDH4* P value Total Low CDH1 High CDH1 P value
Gender
Female 39 31 8 1.00 16 13 3 0.23
Male 28 22 6 14 8 6
Age
≤55 38 27 11 0.07 16 12 4 0.69
>55 29 26 3 14 9 5
Stage
Early 31 20 11 0.01** 12 7 5 0.41
Late 36 33 3 18 14 4
Invasion
No 28 21 7 0.55 11 7 4 0.69
Yes 39 32 7 19 14 5
Metastasis
(Lymph node and distant) No 51 38 13 0.16 25 17 8 1.00
Yes 16 15 1 5 4 1
*

Because of limited samples number, the expression of CDH4 and CDH1 was divided into two levels, in which low expression included the Negative and weakly positive as shown in Table 1 and 3, and high expression included positive and strongly positive.

**

P<0.05.